摘要
【摘 要】目的：探索介入栓塞治疗原发性肝癌合并肝动脉静脉瘘的临床疗效。方法：选择 120例原发性肝癌合并肝动脉静脉瘘患者为试验对象，选择抓阄随机化分组，各 60例，对照组采用先化疗后堵塞治疗，观察组采用先堵塞后介入栓塞。结果：观察组 ALT（ 59.68±3.62） U/L、 AST（ 41.02±4.26） U/L优于对照组，不良反应发生率（ 3.33%）低于对照组（ P<0.05）。结论：对原发性肝癌合并肝动脉静脉瘘患者实施介入栓塞效果显著。
【关键词】介入栓塞 ;原发性肝癌 ;肝动脉静脉瘘
[Abstract] Objective: To explore the clinical efficacy of transcatheter arterial embolization (TACE) in the treatment of hepatocellular carcinoma (HCC) with hepatic arteriovenous fistula (HVF). Methods: 120 patients with primary liver cancer complicated with hepatic arteriovenous fistula were selected as the experimental objects, 60 cases in each group were randomly divided into control group and observation group. Results: ALT (59.68 ± 3.62) U / L and AST (41.02 ± 4.26) U / L in the observation group were better than those in the control group, and the incidence of adverse reactions (3.33%) was lower than that in the control group (P < 0.05). Conclusion: the effect of interventional embolization on primary liver cancer patients with hepatic arteriovenous fistula is significant.
出版日期
2020年09月21日（中国期刊网平台首次上网日期，不代表论文的发表时间）
